Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(67%)

Phase Distribution

Ph phase_4
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 3 finished

Non-Completion Rate

100.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Terminated(3)

Detailed Status

Terminated2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
0.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (100.0%)

Trials by Status

terminated267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
withdrawnphase_4

Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.

NCT06114121
terminatedphase_4

Low Pain Prediction in Cesarean Section Patients

NCT02143141
terminatedphase_4

Multimodal Analgesia in Cardiac Surgery (Pilot Study)

NCT02734940

Clinical Trials (3)

Showing 3 of 3 trials
NCT06114121Phase 4

Intrathecal Morphine vs. Intrathecal Morphine and Regional Anesthesia After Cesarean Section.

Withdrawn
NCT02143141Phase 4

Low Pain Prediction in Cesarean Section Patients

Terminated
NCT02734940Phase 4

Multimodal Analgesia in Cardiac Surgery (Pilot Study)

Terminated

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3